BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Izurieta P, Bahety P, Adegbola R, Clarke C, Hoet B. Public health impact of pneumococcal conjugate vaccine infant immunization programs: assessment of invasive pneumococcal disease burden and serotype distribution. Expert Review of Vaccines 2018;17:479-93. [DOI: 10.1080/14760584.2018.1413354] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Løvlie A, Vestrheim DF, Aaberge IS, Steens A. Changes in pneumococcal carriage prevalence and factors associated with carriage in Norwegian children, four years after introduction of PCV13. BMC Infect Dis 2020;20:29. [PMID: 31924177 DOI: 10.1186/s12879-019-4754-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
2 Letang E, Rakislova N, Martinez MJ, Carlos Hurtado J, Carrilho C, Bene R, Mandomando I, Quintó L, Nhampossa T, Chicamba V, Luis E, Ismail MR, Fernandes F, Lorenzoni C, Ferreira L, Freire M, Teresa Rodrigo-Calvo M, Guerrero J, Munguambe K, Maixenchs M, Navarro M, Casas I, Marimon L, Ferrando M, Macete E, Lacerda M, Bassat Q, Menéndez C, Ordi J. Minimally Invasive Tissue Sampling: A Tool to Guide Efforts to Reduce AIDS-Related Mortality in Resource-Limited Settings. Clin Infect Dis 2021;73:S343-50. [PMID: 34910173 DOI: 10.1093/cid/ciab789] [Reference Citation Analysis]
3 Maraki S, Mavromanolaki VE, Stafylaki D, Hamilos G, Samonis G. The Evolving Epidemiology of Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Strains Isolated from Adults in Crete, Greece, 2009-2016. Infect Chemother 2018;50:328-39. [PMID: 30600656 DOI: 10.3947/ic.2018.50.4.328] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
4 Schulz PS, Moore SE, Smith D, Javed J, Wilde AM. Missed Pneumococcal Vaccination Opportunities in Adults With Invasive Pneumococcal Disease in a Community Health System. Open Forum Infectious Diseases 2022;9:ofac075. [DOI: 10.1093/ofid/ofac075] [Reference Citation Analysis]
5 Shahid S, Khan A, Nisar MI, Khalid F, Qazi MF, Ahmed S, Kabir F, Hotwani A, Muneer S, Ali SA, Whitney CG, Zaidi AKM, Jehan F. Pneumococcal Carriage in Infants Post-PCV10 Introduction in Pakistan: Results from Serial Cross-Sectional Surveys. Vaccines (Basel) 2022;10:971. [PMID: 35746579 DOI: 10.3390/vaccines10060971] [Reference Citation Analysis]
6 Baqui AH, Koffi AK, McCollum ED, Roy AD, Chowdhury NH, Rafiqullah I, Ahmed ZB, Mahmud A, Begum N, Ahmed S, Khanam R, Harrison M, Simmons N, Hossen S, Islam M, Quaiyum A, Checkley W, Santosham M, Moulton LH, Saha SK; Projahnmo Study Group in Bangladesh. Impact of national introduction of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in Bangladesh: Case-control and time-trend studies. Vaccine 2021;39:5794-801. [PMID: 34465471 DOI: 10.1016/j.vaccine.2021.08.068] [Reference Citation Analysis]
7 Kitano T, Aoki H. The incremental burden of invasive pneumococcal disease associated with a decline in childhood vaccination using a dynamic transmission model in Japan: A secondary impact of COVID-19. Comput Biol Med 2021;133:104429. [PMID: 33930765 DOI: 10.1016/j.compbiomed.2021.104429] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Müller A, Schramm DB, Kleynhans J, de Gouveia L, Meiring S, Ramette A, von Gottberg A, Hathaway LJ. Cytokine response in cerebrospinal fluid of meningitis patients and outcome associated with pneumococcal serotype. Sci Rep 2021;11:19920. [PMID: 34620928 DOI: 10.1038/s41598-021-99190-3] [Reference Citation Analysis]
9 Scelfo C, Menzella F, Fontana M, Ghidoni G, Galeone C, Facciolongo NC. Pneumonia and Invasive Pneumococcal Diseases: The Role of Pneumococcal Conjugate Vaccine in the Era of Multi-Drug Resistance. Vaccines (Basel) 2021;9:420. [PMID: 33922273 DOI: 10.3390/vaccines9050420] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Savrasova L, Krumina A, Cupeca H, Zeltina I, Villerusha A, Grope I, Viksna L, Dimina E, Balasegaram S. Invasive Pneumococcal Disease in Latvia in PCV10 Vaccination Era, 2012-2018. Front Pediatr 2021;9:532489. [PMID: 34692599 DOI: 10.3389/fped.2021.532489] [Reference Citation Analysis]
11 Nzoyikorera N, Diawara I, Fresia P, Maaloum F, Katfy K, Nayme K, Maaloum M, Cornick J, Chaguza C, Timinouni M, Belabess H, Zerouali K, Elmdaghri N. Whole genomic comparative analysis of Streptococcus pneumoniae serotype 1 isolates causing invasive and non-invasive infections among children under 5 years in Casablanca, Morocco. BMC Genomics 2021;22:39. [PMID: 33413118 DOI: 10.1186/s12864-020-07316-0] [Reference Citation Analysis]
12 Edmondson-Jones M, Dibbern T, Hultberg M, Anell B, Medin E, Feng Y, Talarico C. The effect of pneumococcal conjugate vaccines on otitis media from 2005 to 2013 in children aged ≤5 years: a retrospective cohort study in two Swedish regions. Hum Vaccin Immunother 2021;17:517-26. [PMID: 32574101 DOI: 10.1080/21645515.2020.1775455] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 van der Linden M, Imöhl M, Perniciaro S. Limited indirect effects of an infant pneumococcal vaccination program in an aging population. PLoS One 2019;14:e0220453. [PMID: 31369597 DOI: 10.1371/journal.pone.0220453] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
14 Guzman-Holst A, de Barros E, Rubio P, DeAntonio R, Cintra O, Abreu A. Impact after 10-year use of pneumococcal conjugate vaccine in the Brazilian national immunization program: an updated systematic literature review from 2015 to 2020. Hum Vaccin Immunother 2021;:1-17. [PMID: 33735585 DOI: 10.1080/21645515.2021.1879578] [Reference Citation Analysis]
15 David SC, Laan Z, Minhas V, Chen AY, Davies J, Hirst TR, McColl SR, Alsharifi M, Paton JC. Enhanced safety and immunogenicity of a pneumococcal surface antigen A mutant whole-cell inactivated pneumococcal vaccine. Immunol Cell Biol 2019;97:726-39. [PMID: 31050022 DOI: 10.1111/imcb.12257] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
16 Beissbarth J, Smith-vaughan HC, Cheng AC, Morris PS, Leach AJ. BIGDATA: A Protocol to Create and Extend a 25-Year Clinical Trial and Observational Data Asset to Address Key Knowledge Gaps in Otitis Media and Hearing Loss in Australian Aboriginal and Non-Aboriginal Children. Front Pediatr 2022;10:804373. [DOI: 10.3389/fped.2022.804373] [Reference Citation Analysis]
17 Lister AJJ, Le CF, Cheah ESG, Desa MNM, Cleary DW, Clarke SC. Serotype distribution of invasive, non-invasive and carried Streptococcus pneumoniae in Malaysia: a meta-analysis. Pneumonia (Nathan) 2021;13:9. [PMID: 34030731 DOI: 10.1186/s41479-021-00086-7] [Reference Citation Analysis]
18 Sabbar H, Mahraoui C, Bastìas Garcià M, Jroundi I. Streptococcus pneumoniae vaccination strategies and its expected impact on penicillin non-susceptibility in children under the age of five: Let's recap! Vaccine X 2022;11:100170. [PMID: 35620569 DOI: 10.1016/j.jvacx.2022.100170] [Reference Citation Analysis]
19 Belcher T, Kammoun H, Coutte L, Debrie AS, Mielcarek N, Sirard JC, Cauchi S, Locht C. Live attenuated Bordetella pertussis vaccine candidate BPZE1 transiently protects against lethal pneumococcal disease in mice. Vaccine 2021:S0264-410X(21)00041-4. [PMID: 33509692 DOI: 10.1016/j.vaccine.2021.01.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Verhagen LM, Rivera-Olivero IA, Clerc M, Chu MLJN, van Engelsdorp Gastelaars J, Kristensen MI, Berbers GAM, Hermans PWM, de Jonge MI, de Waard JH, Bogaert D. Nasopharyngeal Microbiota Profiles in Rural Venezuelan Children Are Associated With Respiratory and Gastrointestinal Infections. Clin Infect Dis 2021;72:212-21. [PMID: 31919525 DOI: 10.1093/cid/ciaa015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
21 Briles DE, Paton JC, Mukerji R, Swiatlo E, Crain MJ. Pneumococcal Vaccines. Microbiol Spectr 2019;7. [PMID: 31858954 DOI: 10.1128/microbiolspec.GPP3-0028-2018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
22 Sings HL, Gessner BD, Wasserman MD, Jodar L. Pneumococcal Conjugate Vaccine Impact on Serotype 3: A Review of Surveillance Data. Infect Dis Ther 2021;10:521-39. [PMID: 33587245 DOI: 10.1007/s40121-021-00406-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Nieto Guevara J, Izurieta P. Reply to 'Emergence of Streptococcus pneumoniae serotype 19A (Spn19A) in the pediatric population in Bogotá, Colombia as the main cause of invasive pneumococcal disease after the introduction of PCV10'. Hum Vaccin Immunother 2020;16:2307-8. [PMID: 32643508 DOI: 10.1080/21645515.2020.1784654] [Reference Citation Analysis]
24 Lecrenier N, Marijam A, Olbrecht J, Soumahoro L, Nieto Guevara J, Mungall B. Ten years of experience with the pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine ( Synflorix ) in children. Expert Review of Vaccines 2020;19:247-65. [DOI: 10.1080/14760584.2020.1738226] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
25 Agudelo CI, Castañeda-Orjuela C, Brandileone MCC, Echániz-Aviles G, Almeida SCG, Carnalla-Barajas MN, Regueira M, Fossati S, Alarcón P, Araya P, Duarte C, Sánchez J, Novas M, Toraño-Peraza G, Rodríguez-Ortega M, Chamorro-Cortesi G, Kawabata A, García-Gabarrot G, Camou T, Spadola E, Payares D, Andrade AL, Di Fabio JL, Castañeda E; SIREVA Working Group. The direct effect of pneumococcal conjugate vaccines on invasive pneumococcal disease in children in the Latin American and Caribbean region (SIREVA 2006-17): a multicentre, retrospective observational study. Lancet Infect Dis 2021;21:405-17. [PMID: 32986996 DOI: 10.1016/S1473-3099(20)30489-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
26 Vestjens SMT, Sanders EAM, Vlaminckx BJ, de Melker HE, van der Ende A, Knol MJ. Twelve years of pneumococcal conjugate vaccination in the Netherlands: Impact on incidence and clinical outcomes of invasive pneumococcal disease. Vaccine 2019;37:6558-65. [PMID: 31500963 DOI: 10.1016/j.vaccine.2019.08.025] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
27 Ouldali N, Cohen R, Levy C, Gelbert-Baudino N, Seror E, Corrard F, Vie Le Sage F, Michot AS, Romain O, Bechet S, Bonacorsi S, Angoulvant F, Varon E. Pneumococcal susceptibility to antibiotics in carriage: a 17 year time series analysis of the adaptive evolution of non-vaccine emerging serotypes to a new selective pressure environment. J Antimicrob Chemother 2019;74:3077-86. [PMID: 31280295 DOI: 10.1093/jac/dkz281] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
28 Ruiz García Y, Nieto Guevara J, Izurieta P, Vojtek I, Ortega-Barría E, Guzman-Holst A. CIRCULATING CLONAL COMPLEXES AND SEQUENCE TYPES OF STREPTOCOCCUS PNEUMONIAE SEROTYPE 19A WORLDWIDE: THE IMPORTANCE OF MULTIDRUG RESISTANCE: A SYSTEMATIC LITERATURE REVIEW. Expert Rev Vaccines 2021;20:45-57. [PMID: 33507135 DOI: 10.1080/14760584.2021.1873136] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Izurieta P, Nieto Guevara J. Exploring the evidence behind the comparable impact of the pneumococcal conjugate vaccines PHiD-CV and PCV13 on overall pneumococcal disease. Hum Vaccin Immunother 2021;:1-8. [PMID: 33605846 DOI: 10.1080/21645515.2021.1872341] [Reference Citation Analysis]
30 Platt HL, Greenberg D, Tapiero B, Clifford RA, Klein NP, Hurley DC, Shekar T, Li J, Hurtado K, Su SC, Nolan KM, Acosta CJ, McFetridge RD, Bickham K, Musey LK; V114-008 Study Group. A Phase II Trial of Safety, Tolerability and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, Compared With 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants. Pediatr Infect Dis J 2020;39:763-70. [PMID: 32639460 DOI: 10.1097/INF.0000000000002765] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 9.0] [Reference Citation Analysis]
31 Oligbu G, Fry NK, Ladhani SN. The Epidemiology and Biostatistics of Pneumococcus. Methods Mol Biol 2019;1968:215-24. [PMID: 30929218 DOI: 10.1007/978-1-4939-9199-0_18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
32 Oliveira DS, Chiaravalloti Neto F, Mota TS, Araujo DB, Sartori AMC. Spatial analysis of pneumococcal meningitis in São Paulo in the pre- and post-immunization era. Rev Saude Publica 2019;53:59. [PMID: 31340351 DOI: 10.11606/S1518-8787.2019053001183] [Reference Citation Analysis]
33 Passaris I, Mauder N, Kostrzewa M, Burckhardt I, Zimmermann S, van Sorge NM, Slotved HC, Desmet S, Ceyssens PJ. Validation of Fourier Transform Infrared Spectroscopy for Serotyping of Streptococcus pneumoniae. J Clin Microbiol 2022;:e0032522. [PMID: 35699436 DOI: 10.1128/jcm.00325-22] [Reference Citation Analysis]
34 Feldman C, Anderson R. Recent advances in the epidemiology and prevention of Streptococcus pneumoniae infections. F1000Res 2020;9:F1000 Faculty Rev-338. [PMID: 32411353 DOI: 10.12688/f1000research.22341.1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
35 Kohns Vasconcelos M, Loens K, Sigfrid L, Iosifidis E, Epalza C, Donà D, Matheeussen V, Papachristou S, Roilides E, Gijon M, Rojo P, Minotti C, Da Dalt L, Islam S, Jarvis J, Syggelou A, Tsolia M, Nyirenda Nyang'wa M, Keers S, Renk H, Gemmel AL, D'Amore C, Ciofi Degli Atti M, Rodríguez-Tenreiro Sánchez C, Martinón-Torres F, Burokienė S, Goetghebuer T, Spoulou V, Riordan A, Calvo C, Gkentzi D, Hufnagel M, Openshaw PJ, de Jong MD, Koopmans M, Goossens H, Ieven M, Fraaij PLA, Giaquinto C, Bielicki JA, Horby P, Sharland M. Aetiology of acute respiratory infection in preschool children requiring hospitalisation in Europe-results from the PED-MERMAIDS multicentre case-control study. BMJ Open Respir Res 2021;8:e000887. [PMID: 34326154 DOI: 10.1136/bmjresp-2021-000887] [Reference Citation Analysis]
36 Mungall BA, Hoet B, Nieto Guevara J, Soumahoro L. A systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in children. Expert Rev Vaccines 2021. [PMID: 34882050 DOI: 10.1080/14760584.2022.2012455] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Ludwig G, Garcia-Garcia S, Lanaspa M, Ciruela P, Esteva C, Fernandez de Sevilla M, Diaz-Conradi A, Marti C, Motje M, Galles C, Morta M, Izquierdo C, Moraga-Llop F, Campins M, Salleras L, Jane M, Dominguez A, Garcia-Garcia JJ, Muñoz-Almagro C; Catalan Study Group of Invasive Pneumococcal Disease. Serotype and clonal distribution dynamics of invasive pneumococcal strains after PCV13 introduction (2011-2016): Surveillance data from 23 sites in Catalonia, Spain. PLoS One 2020;15:e0228612. [PMID: 32027715 DOI: 10.1371/journal.pone.0228612] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
38 Tantawichien T, Hsu LY, Zaidi O, Bernauer M, Du F, Yamada E, Kim JO, Sukarom I. Systematic literature review of the disease burden and vaccination of pneumococcal disease among adults in select Asia-Pacific areas. Expert Rev Vaccines 2021;:1-12. [PMID: 34894996 DOI: 10.1080/14760584.2022.2016399] [Reference Citation Analysis]
39 Hanquet G, Krizova P, Dalby T, Ladhani SN, Nuorti JP, Danis K, Mereckiene J, Knol MJ, Winje BA, Ciruela P, de Miguel S, Portillo ME, MacDonald L, Morfeldt E, Kozakova J, Valentiner-Branth P, Fry NK, Rinta-Kokko H, Varon E, Corcoran M, van der Ende A, Vestrheim DF, Munoz-Almagro C, Sanz JC, Castilla J, Smith A, Henriques-Normark B, Colzani E, Pastore-Celentano L, Savulescu C; SpIDnet group1. Serotype Replacement after Introduction of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines in 10 Countries, Europe. Emerg Infect Dis 2022;28:137-8. [PMID: 34932457 DOI: 10.3201/eid2801.210734] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
40 Baqui AH, McCollum ED, Mahmud A, Roy A, Chowdhury NH, Rafiqullah I, Rizvi SJR, Begum N, Mitra DK, Khanam R, Harrison M, Ahmed S, Hasanuzzaman M, Rahman H, Islam M, Ahmed ZB, Quaiyum MA, Koffi A, Simmons N, Checkley W, Moulton LH, Santosham M, Saha SK; Projahnmo Study Group in Bangladesh. Population-based incidence and serotype distribution of invasive pneumococcal disease prior to introduction of conjugate pneumococcal vaccine in Bangladesh. PLoS One 2020;15:e0228799. [PMID: 32053640 DOI: 10.1371/journal.pone.0228799] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
41 Ouldali N, Varon E, Levy C, Angoulvant F, Georges S, Ploy MC, Kempf M, Cremniter J, Cohen R, Bruhl DL, Danis K. Invasive pneumococcal disease incidence in children and adults in France during the pneumococcal conjugate vaccine era: an interrupted time-series analysis of data from a 17-year national prospective surveillance study. Lancet Infect Dis 2021;21:137-47. [PMID: 32702302 DOI: 10.1016/S1473-3099(20)30165-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
42 Izurieta P, Scherbakov M, Nieto Guevara J, Vetter V, Soumahoro L. Systematic review of the efficacy, effectiveness and impact of high-valency pneumococcal conjugate vaccines on otitis media. Hum Vaccin Immunother 2022;:1-18. [PMID: 35020530 DOI: 10.1080/21645515.2021.2013693] [Reference Citation Analysis]